Xeris Pharmaceuticals
Austin, US · Delaware corporation · 1 known investors
Find your way into Xeris Pharmaceuticals
203 people in our graph share verified history with the Xeris Pharmaceuticals team — schools, employers, funds. One of them is your warm intro.
Paxton Majorunlockedknows Yash Sabharwal · together at QbDVision (overlapped)
×9knows the team · via University of Rochester
knows the team · via University of Arizona
knows the team · via Roper Industries
Founders & leadership
SP
Steven PrestrelskiCo-founder
DB
Douglas BaumCo-founder
JK
John KinzellCo-founder
PS
Poul StrangeExecutive
YS
Yash SabharwalinCOO/CFO2010–2014Executive officer at Xeris Pharmaceuticals. Previously founded QbDVision, which provides software for digital management of product and process development in pharmaceutical and biotech manufacturing.
Board
RF
Robert FaulkerBoard director
CM
Cary McNairBoard director
TS
Timothy SullivanBoard director
SB
Shane BrisbinBoard director
NP
Navneet PuriBoard director
JR
Jonathan RigbyBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$82.3M disclosed across 3 rounds · 2014–2017
▶$30.1MraisedMay 2017 · 22 investors · PharmaceuticalsRule 506(b)
▶$30.1MraisedMay 2017 · 22 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Paul EdickExecutive Officer, Director
- Cary McNairDirector
- John ShannonExecutive Officer
- Robert FaulkerDirector
- Navneet PuriDirector
- Brad HuckabeeExecutive Officer
- Jonathan RigbyDirector
- Offering amount
- $45M
- Amount sold
- $30.1M
- First sale
- May 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$45MraisedDec 2016 · 48 investors · PharmaceuticalsRule 506(b)
▶$45MraisedDec 2016 · 48 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert FaulkerDirector
- Poul StrangeExecutive Officer
- Navneet PuriDirector
- Steven PrestrelskiExecutive Officer
- Cary McNairDirector
- Douglas BaumExecutive Officer, Director
- Jonathan RigbyDirector
- Offering amount
- $50M
- Amount sold
- $45M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.3MraisedSep 2014 · 56 investors · Other TechnologyRule 506(b)
▶$7.3MraisedSep 2014 · 56 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Yash SabharwalExecutive Officer
- John KinzellExecutive Officer, Director
- Timothy SullivanDirector
- Douglas BaumExecutive Officer, Director
- Shane BrisbinDirector
- Steven PrestrelskiExecutive Officer
- Offering amount
- $14.9M
- Amount sold
- $7.3M
- Minimum investment
- $25K
- Finders' fees
- $55.5K
- First sale
- Sep 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Xeris Pharmaceuticals?
- Xeris Pharmaceuticals was founded by Steven Prestrelski, Douglas Baum, John Kinzell.
- Who are Xeris Pharmaceuticals's investors?
- Xeris Pharmaceuticals's investors include Bay City Capital.
- How much funding has Xeris Pharmaceuticals raised?
- Xeris Pharmaceuticals has disclosed $82.3M raised across 3 rounds.
- Where is Xeris Pharmaceuticals headquartered?
- Xeris Pharmaceuticals is headquartered in Austin, US.